Firm
Plasseraud IP says it is eyeing AI and quantum computing expertise with new hire from Cabinet Netter
    
    
      
        
    
      
    
    
    
  McGuireWoods’ focussed experimentation and disciplined execution of AI tools is sharpening its IP practice 
    
    
      
        
    
      
    
    
    
  As Marshall Gerstein celebrates its 70-year anniversary, Jeffrey Sharp, managing partner, reflects on lessons that shaped both his career and the firm’s success
    
    
      
        
    
      
    
    
    
  News of two pharma deals involving Novo Nordisk and GSK and a loss for Open AI were also among the top talking points
    
    
      
        
    
      
    
    
    
  
        Sponsored
      
    
    
      Sponsored
- 
          
            Sponsored by Wanhuida Intellectual PropertyMinnan (Miranda) Xie of Wanhuida Intellectual Property analyses how China’s patent authorities and courts assess second medical use inventions, with key CNIPA decisions clarifying the treatment of dosage regimens and patient subgroups in novelty determinations
 - 
          
            Sponsored by InventaVítor Palmela Fidalgo of Inventa examines how Portuguese case law diverges from EU rules on acquired distinctiveness, highlighting the Pão de Rio Maior decision and its implications for trademark interpretation and consumer protection
 - 
          
            Sponsored by Tilleke & GibbinsVietnam’s boom in AI-generated songs raises fundamental copyright questions, say Linh Duy Mai and Diep Thi Bich Le of T&G Law Firm LLC (TGVN), the local associate of Tilleke & Gibbins
 - 
          
            Sponsored by Hanol IP & LawMin Son of Hanol IP & Law explains why the ruling by South Korea’s Intellectual Property High Court marks a key development in online patent enforcement
 - 
          
            Sponsored by Becerril, Coca & BecerrilCarlos Hernández León of Becerril, Coca & Becerril outlines how Mexico’s shift from NAFTA-based patent term extensions to the new SPC regime affects patent holders , particularly in pharmaceuticals, and the strategic steps to secure additional protection
 - 
          
            Sponsored by InspicosEdward J Farrington of Inspicos explains how G 2/24 confirms that a third-party intervener does not acquire appellant status once all original appeals are withdrawn